Mirus Capital AdvisorsMirus Capital Advisors

Sunday, March 15, 2015

A 10-Year Review & Analysis of Med-Tech Funding Trends

In the past, the next step would be for venture or institutional funds to take technology through to approval and market introduction. For a fairly straightforward 510K device this might be another $1 to 3 million. For a PMA device it could run upwards of $30 to 50 million or more. No matter where you are […]

Thursday, February 26, 2015

Harpoon Brewery: What’s Beer Got To Do With M&A?

Well, not much, really, except that Charlie Storey, President, and Warren Dibble, the CFO of Harpoon Brewery completed an ESOP of the company last summer.  They’re coming to this year’s XPX Summit on March 19th at the Waltham Woods Conference Center to tell their story.  Check out their video to get a taste.  Oh – […]

Monday, January 12, 2015

A Review of 2014 Medical Device M&A

The Medical Device Industry Goes Big in 2014 It has clearly been an exciting year in the medical device M&A space if one is stimulated by sheer deal size. Three of the top ten healthcare acquisitions of the year are medical device deals, with the Medtronic/Covidien blockbuster leading the way. Top 10 Largest Health Care […]

Monday, December 15, 2014

Counting the Cash: Deals in Medical Revenue Cycle Management Ticking Up

Medical revenue cycle management is a little known (to the public) business service that involves helping healthcare professionals get paid.  It includes software to automate the process of submitting claims, as well as service providers, who ensure that every claim contains the appropriate service code and diagnosis code to maximize reimbursement. While there aren’t typically […]

Tuesday, November 18, 2014

$100 billion of M&A in a day

“Merger Madness” was the headline this Monday as $100 billion in deals were announced.  Halliburton (acquiring Baker Hughes) and Actavis (acquiring Allergan) shared the spotlight. These two big deals are just the latest in an already strong year for M&A.  The total value for acquisitions of U.S. companies stood at $1.354 trillion before Monday’s news, up […]

Saturday, November 08, 2014

M&A: Keep it clean. Disposables, protective equipment, single-use technologies, and cleanroom operations on the rise.

  The world can be a messy place.  Companies that focus on keeping it a bit (or a lot) cleaner play an important role in public health, medical research and pharmaceutical manufacturing, to name just a few areas.   The economic impact of contamination in those fields can be tremendous.  Add to that the public […]

Thursday, July 24, 2014

Risk-Aversion Dwarfed by Demand for Growth

CEO’s are feeling increasing pressure from their shareholders to manufacture increasing levels of growth. To that end, there is a shift away from more conservative stock buy-back programs to riskier mergers and acquisitions, as demonstrated below. More specifically, closed US stock buy-back activity decreased precipitously from a high of $60B in Q2 2013 to $12M […]

Friday, June 27, 2014

Recurring revenue counts in industries far beyond software

The recurring revenue (“RR”) business model gets a lot of attention in software M&A and growth investment, and for good reason.  Most growing subscription/ software-as-a-service (SaaS)-based software companies trade in the public markets for north of 6x revenue and many of those fortunate few with annual revenue growth over 40% trade for over 10x revenue. […]